BAY CITY CAPITAL LLC's Net Worth
Estimate Recalculated Jun 18, 2025 08:57PM EST
Who is BAY CITY CAPITAL LLC
BAY CITY CAPITAL LLC has an estimated net worth of $8.55 Million. This is based on reported shares across multiple companies, which include DIAMETRICS MEDICAL INC, EnteroMedics Inc, SYNTA PHARMACEUTICALS CORP, HYPERION THERAPEUTICS INC, Kezar Life Sciences, Inc., NEVRO CORP, Dermira, Inc., Xilio Therapeutics, Inc., NEORX CORP, Epizyme, Inc., SUNESIS PHARMACEUTICALS INC, IMARA Inc., INTERLEUKIN GENETICS INC, and CORAUTUS GENETICS INC.
SEC CIK
BAY CITY CAPITAL LLC's CIK is 0001288452
Past Insider Trading and Trends
2007 was BAY CITY CAPITAL LLC's most active year for acquiring shares with 24 total transactions. BAY CITY CAPITAL LLC's most active month to acquire stocks was the month of July. 2013 was BAY CITY CAPITAL LLC's most active year for disposing of shares, totalling 42 transactions. BAY CITY CAPITAL LLC's most active month to dispose stocks was the month of June. 2009 saw BAY CITY CAPITAL LLC paying a total of $13,149,423.16 for 89,472,386 shares, this is the most they've acquired in one year. In 2015 BAY CITY CAPITAL LLC cashed out on 491,835 shares for a total of $23,578,569.90, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
